作为COVID-19进展的预测器的CXCL9/10/11-CXCR3轴:一个前性的病例控制研究
Neslihan Çelik1, Onur Çelik2, Esra Laloğlu3
1Health Sciences University, Erzurum Regional Education and Research Hospital, Department of Infection Diseases and Clinical Microbiology, Erzurum, Turkey.
化基因 (CXCL9,CXCL10,CXCL11) 和受体 (CXCR3) 水平与COVID-19的严重程度和死亡率相关. 更高的水平表明更糟糕的结果,有助于临床决策对患者的预后.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 临床医学 临床医学
背景情况:
- COVID-19的发病过程涉及复杂的免疫反应.
- 化基因及其受体在炎症性疾病中起作用.
研究的目的:
- 研究CXCL9,CXCL10,CXCL11和CXCR3水平与COVID-19患者死亡率之间的关联.
- 为了确定这些标记能否预测疾病的严重程度.
主要方法:
- 与酶相关的免疫吸收试验 (ELISA) 用于测量CXCL9,CXCL10,CXCL11和CXCR3.3的血清水平.
- 研究包括71名住院COVID-19患者和35名健康对照.
- 患者根据疾病严重程度 (轻度,中度,严重) 和结局 (幸存者,死者) 分类.
主要成果:
- 严重的CXCL9,CXCL10,CXCL11和CXCR3水平在严重的COVID-19患者中明显升高,与不严重的病例相比.
- 这两组COVID-19患者的化学激素水平都高于健康对照组.
- 与幸存者相比,已故患者表现出较高水平的这些化学激素.
结论:
- CXCL9,CXCL10,CXCL11和CXCR3水平与COVID-19疾病严重程度有显著的相关性.
- 这些生物标志物可以作为预测患者结果和指导临床管理决策的有价值指标.
更多相关视频
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Single Nucleotide Polymorphisms-SNPs
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
